2WU-13729-43065

2 vaccinations 6 coded responses 9 check-ins 6 free-text entries 4 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 935 / CA
Registered: 2021-10-04

Relationship: Self
Race: Black or African American
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-08
Dose 1 — Pfizer-BioNTech
2021-09-29
Dose 2 — Pfizer-BioNTech
2021-10-04
Registered in v-safe
2021-10-04
Survey response — days 1–6 daily, dose 2
MedDRA: Migraine with aura — Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Migraine aura

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Report sent to call center — days 1–6 daily, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2021-10-05
Call successful
Participant prefers to complete VAERS report online
2021-10-06
Survey response — day 7, dose 2
MedDRA: Chest pain, Hypoaesthesia, Hypotension, Seizure — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Seizures, Low Blood Pressure, Chest Pain, Numbness

MedDRA releases: 2024-11 · check-in free text available
2021-10-13
Survey response — day 14, dose 2
MedDRA: Chest pain, Disturbance in attention, Dyspnoea, Emergency care, Impaired work ability, Loss of personal independence in daily activities, Office visit, Pain, Seizure, Speech disorder, Tremor — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Symptoms: 10/6/21 went to the ER a 2nd time due to continuing tremors/convulsions, trouble speaking, chest pain, shortness of breath, unable to concentrate, pain moving through different parts of my body. Since 9/30/21, I am unable to work/need ADL assistance. · Healthcare visit (other): I am currently being treated by a Neurologist and my Primary Care Physician. I have an EEG test on 10/14/21.

MedDRA releases: 2024-11 · check-in free text available
2021-10-13
Report sent to call center — day 14, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2021-10-14
Call 1 — Could Not Reach Participant
2021-10-19
Call 2 — Could Not Reach Participant
2021-10-21
Health check-in — day 21, dose 2
Feeling: Poor

Adult check-in
2021-10-27
Survey response — day 28, dose 2
MedDRA: Hyperacusis, Impaired work ability, Photophobia, Seizure, Speech disorder, Tremor — Feeling: Poor · Be unable to work or attend school

Free text: Not able to work after receiving the 2nd Pfizer Vaccine on 9/29/21. Still experiencing non epileptic seizures, tremors, speech deficits, sensitivity to light, sounds. Being treated.

MedDRA releases: 2024-11 · check-in free text available
2021-11-08
Survey response — day 35, dose 2
MedDRA: Seizure, Speech disorder, Tremor — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Non-epileptic seizures, heavy tremors, speech deficits

MedDRA releases: 2024-11 · check-in free text available
2021-11-08
Report sent to call center — day 35, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-11-09
Call 1 — Could Not Reach Participant
2021-11-12
Call 2 — Could Not Reach Participant
2021-12-29
Health check-in — 3 months, dose 2
Feeling: Poor

Adult check-in
2022-03-30
Survey response — 6 months, dose 2
MedDRA: Anxiety, Electric shock sensation, Hypoaesthesia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Increase in numbness in hands and feet while sleeping. Electricity type pain in fingers and feet. Sudden anxiety when relaxed.

MedDRA releases: 2024-11 · check-in free text available
2022-03-30
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-31
Call successful
Other
2022-09-29
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-08	Pfizer-BioNTech	No
2	2021-09-29	Pfizer-BioNTech	No

Call center

4 call center cases

4 successful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 2

2021-10-04

Systemic reaction (other): Migraine aura

Release 10 — day 7, dose 2

2021-10-06

Systemic reaction (other): Seizures, Low Blood Pressure, Chest Pain, Numbness

Release 10 — day 14, dose 2

2021-10-13

Symptoms: 10/6/21 went to the ER a 2nd time due to continuing tremors/convulsions, trouble speaking, chest pain, shortness of breath, unable to concentrate, pain moving through different parts of my body. Since 9/30/21, I am unable to work/need ADL assistance. cut off by CDC

Healthcare visit (other): I am currently being treated by a Neurologist and my Primary Care Physician. I have an EEG test on 10/14/21.

Release 10 — day 28, dose 2

2021-10-27

Symptoms: Not able to work after receiving the 2nd Pfizer Vaccine on 9/29/21. Still experiencing non epileptic seizures, tremors, speech deficits, sensitivity to light, sounds. Being treated.

Release 10 — day 35, dose 2

2021-11-08

Symptoms: Non-epileptic seizures, heavy tremors, speech deficits

Release 11 — 6 months, dose 2

2022-03-30

Symptoms: Increase in numbness in hands and feet while sleeping. Electricity type pain in fingers and feet. Sudden anxiety when relaxed.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Anxiety	·	·	✓
SD	Chest pain	·	·	✓
SD	Disturbance in attention	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Electric shock sensation	·	·	✓
SD	Emergency care	·	·	✓
SD	Hyperacusis	·	·	✓
SD	Hypoaesthesia	·	·	✓
SD	Impaired work ability	·	·	✓
SD	Loss of personal independence in daily activities	·	·	✓
SD	Pain	·	·	✓
SD	Photophobia	·	·	✓
SD	Seizure	·	·	✓
SD	Speech disorder	·	·	✓
SD	Tremor	·	·	✓
SRO	Chest pain	·	·	✓
SRO	Hypoaesthesia	·	·	✓
SRO	Hypotension	·	·	✓
SRO	Migraine with aura	·	·	✓
SRO	Seizure	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release